Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control. | Front Immunol | 2023 | 37187762 | PubTator, text mining | PubMed |
| Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma. | Front Oncol | 2023 | 37182147 | PubTator, text mining | PubMed |
| WGCNA and molecular docking identify hub genes for cardiac aging. | Front Cardiovasc Med | 2023 | 37180776 | PubTator, text mining | PubMed |
| Aging-induced pseudouridine synthase 10 impairs hematopoietic stem cells. | Haematologica | 2023 | 37165848 | PubTator, text mining | PubMed |
| Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma. | Sci Rep | 2023 | 37161008 | PubTator, text mining | PubMed |
| Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer. | Oncol Lett | 2023 | 37153058 | PubTator, text mining | PubMed |
Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. | Open Forum Infect Dis | 2023 | 37152187 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer. | J Cancer | 2023 | 37151397 | PubTator, text mining | PubMed |
| Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3. | Sci Rep | 2023 | 37142644 | PubTator, text mining | PubMed |
| Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma. | J Bone Oncol | 2023 | 37139222 | PubTator, text mining | PubMed |
| Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer. | Front Genet | 2023 | 37124627 | PubTator, text mining | PubMed |
| Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer. | Front Oncol | 2023 | 37124502 | PubTator, text mining | PubMed |
| Editorial: Revisiting the thymus: the origin of T cells. | Front Immunol | 2023 | 37122760 | PubTator, text mining | PubMed |
| Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. | Front Immunol | 2023 | 37122750 | PubTator, text mining | PubMed |
| Integrative analyses of biomarkers and pathways for diabetic nephropathy. | Front Genet | 2023 | 37113991 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates for Multiple Myeloma: Just the Beginning, or the Beginning of the End? | Pharmaceuticals (Basel) | 2023 | 37111346 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in CD4+ T Effector Memory RA+ Cells. | Biology (Basel) | 2023 | 37106796 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer. | Evid Based Complement Alternat Med | 2023 | 37101716 | PubTator, text mining | PubMed |
Clonorchis sinensis granulin promotes malignant transformation of human intrahepatic biliary epithelial cells through interaction with M2 macrophages via regulation of STAT3 phosphorylation and the MEK/ERK pathway. | Parasit Vectors | 2023 | 37095578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=22